Gastrointestinal Stromal Tumour (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Condition: Gastrointestinal Stromal Tumors (GISTs)Intervention: Drug: Imatinib MesylateSponsor: Asan Medical CenterRecruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2016 Category: Research Source Type: clinical trials
